News

Journal rejects article after objections from marketing department

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7434.244-b (Published 29 January 2004) Cite this as: BMJ 2004;328:244
  1. Owen Dyer
  1. London

    A leading nephrology journal has rejected a guest editorial questioning the efficacy of epoetin in end stage renal disease, despite favourable peer reviews, apparently because it feared losing advertising. In a letter to the author of the proposed editorial, the executive editor of the California based journal Transplantation and Dialysis said he had been “overruled by our marketing department.”

    The editorial was written by Dennis Cotter, president of the non-profit making Medical Technology and Practice Patterns Institute. In it, he argued that the US National Kidney Foundation's existing guidelines on end stage renal disease …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe